NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 12 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,492 | -99.9% | 7,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $4,998,000 | +13.3% | 7,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $4,410,000 | -36.7% | 7,000 | -30.0% | 0.00% | 0.0% |
| Q1 2022 | $6,970,000 | -0.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $7,000,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 25,915,937 | $14,062,000 | 0.57% |
| Family Management Corp | 105,975 | $58,000 | 0.03% |
| HYMAN CHARLES D | 249,625 | $135,000 | 0.02% |
| Montecito Bank & Trust | 75,717 | $41,000 | 0.02% |
| WEDBUSH SECURITIES INC | 162,200 | $88,000 | 0.01% |
| Cutler Group LLC / CA | 9,600 | $105,000 | 0.01% |
| WHALEROCK POINT PARTNERS, LLC | 15,000 | $8,000 | 0.00% |
| TELEMUS CAPITAL, LLC | 32,401 | $18,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 15,504 | $8,000 | 0.00% |
| Creative Planning | 413,500 | $224,000 | 0.00% |